MabPlex International locks in $59.1 mln Series A

China and California-based MabPlex International Ltd, a contract development and manufacturing organization for the global biopharmaceutical and biotechnology industries, has secured $59.1 million in Series A funding. China's State Development & Investment Corporation and Shenzhen Venture Capital were the lead investors.